Blood and neoplastic diseases. Treatment of the lymphomas.
D000505:Alopecia / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000532:radiotherapy; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011835:Radiation Protection; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D011239:Prednisolone; D011241:Prednisone